Cell Cycle Checkpoints & Growth Factor Signaling - Quick Reference
Checkpoints in the Cell Cycle
- Checkpoints ensure progression only when conditions are favorable: G1/S, G2/M, and the M (metaphase-to-anaphase) checkpoint.
- Cell cycle structure:
- Interphase: G1, ext{ }S, ext{ }G2
- Mitosis: Prophase, Metaphase, Anaphase, Telophase + Cytokinesis as part of the M phase.
Key Regulators of the Cell Cycle
- Proto-oncogenes: genes that promote proliferation and progression.
- Tumor suppressor genes: brakes that inhibit progression when DNA is damaged or not ready.
Growth Factors (Mitogens) and Receptors
- Growth factors examples: Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), Platelet-Derived Growth Factor (PDGF).
- Receptors: G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs).
- Growth factors trigger signaling to drive proliferation.
GPCR (G_q) Pathway to Proliferation
- Ligand binding to a GPCR (often Gq): GDP → GTP on G{ ext{q}} → receptor activation.
- Effector: Phospholipase C (PLC) activated by G_{ ext{q}}.
- PLC action: PIP2
ightarrow DAG + IP3.
- DAG activates Protein Kinase C PKC; IP_3 increases cytosolic Ca^{2+} (from storage).
- Ca^{2+} binds Calmodulin; Ca^{2+}-Calmodulin activates kinases or transcription factors, promoting proto-oncogene expression.
- Overall: signals lead to transcriptional activation and proliferation.
RTK-GRB2 Pathway (Dimerization and Adaptor Signaling)
- Growth factor binding causes RTK dimerization and autophosphorylation.
- Adaptor protein GRB2 links the receptor to downstream signaling.
- Result: activation of transcriptional programs that promote cell cycle progression.
Quick Takeaways
- Proliferation is controlled by a balance between proto-oncogenes (promote) and tumor suppressor genes (inhibit).
- Growth factors via GPCR and RTK pathways drive progression through the cell cycle by activating transcription factors and gene programs.
- Key phosphorylation and second messenger steps include PIP2
ightarrow DAG + IP3, activation of PKC, and Ca^{2+}-dependent signaling.